Commonwealth Equity Services’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.01M | Buy |
59,503
+10,393
| +21% | +$692K | 0.01% | 1582 |
|
|
2026
Q1 | $3.08M | Buy |
49,110
+17,134
| +54% | +$1.19M | ﹤0.01% | 1676 |
|
|
2025
Q4 | $2.12M | Buy |
31,976
+4,268
| +15% | +$276K | ﹤0.01% | 1924 |
|
|
2025
Q3 | $1.86M | Sell |
27,708
-5,406
| -16% | -$428K | ﹤0.01% | 2057 |
|
|
2025
Q2 | $2.89M | Sell |
33,114
-14,464
| -30% | -$1.13M | ﹤0.01% | 1718 |
|
|
2025
Q1 | $3.25M | Buy |
47,578
+3,197
| +7% | +$261K | ﹤0.01% | 1582 |
|
|
2024
Q4 | $3.45M | Sell |
44,381
-1,562
| -3% | -$116K | 0.01% | 1479 |
|
|
2024
Q3 | $3.08M | Sell |
45,943
-4,483
| -9% | -$368K | ﹤0.01% | 1556 |
|
|
2024
Q2 | $5.72M | Sell |
50,426
-1,690
| -3% | -$214K | 0.01% | 1113 |
|
|
2024
Q1 | $7.23M | Buy |
52,116
+4,711
| +10% | +$592K | 0.01% | 951 |
|
|
2023
Q4 | $5.88M | Buy |
47,405
+3,636
| +8% | +$371K | 0.01% | 1012 |
|
|
2023
Q3 | $4.08M | Buy |
43,769
+635
| +1% | +$71.6K | 0.01% | 1141 |
|
|
2023
Q2 | $5.54M | Buy |
43,134
+7,905
| +22% | +$956K | 0.01% | 977 |
|
|
2023
Q1 | $4.09K | Sell |
35,229
-3,451
| -9% | -$386K | 0.01% | 1114 |
|
|
2022
Q4 | $4.38M | Sell |
38,680
-277
| -0.7% | -$30.4K | 0.01% | 1034 |
|
|
2022
Q3 | $3.14M | Sell |
38,957
-1,757
| -4% | -$149K | 0.01% | 1145 |
|
|
2022
Q2 | $3.03M | Buy |
40,714
+3,506
| +9% | +$320K | 0.01% | 1167 |
|
|
2022
Q1 | $4.76M | Sell |
37,208
-9,232
| -20% | -$1.01M | 0.01% | 964 |
|
|
2021
Q4 | $6.23M | Sell |
46,440
-1,832
| -4% | -$263K | 0.01% | 818 |
|
|
2021
Q3 | $6.6M | Buy |
48,272
+13,708
| +40% | +$1.73M | 0.02% | 722 |
|
|
2021
Q2 | $3.69M | Buy |
34,564
+176
| +0.5% | +$16.9K | 0.01% | 1027 |
|
|
2021
Q1 | $3.09M | Sell |
34,388
-4,172
| -11% | -$392K | 0.01% | 1046 |
|
|
2020
Q4 | $3.56M | Sell |
38,560
-25,196
| -40% | -$2.25M | 0.01% | 900 |
|
|
2020
Q3 | $6.57M | Buy |
63,756
+27,124
| +74% | +$2.83M | 0.02% | 564 |
|
|
2020
Q2 | $3.71M | Buy |
36,632
+7,400
| +25% | +$662K | 0.01% | 717 |
|
|
2020
Q1 | $1.97M | Buy |
29,232
+5,508
| +23% | +$343K | 0.01% | 909 |
|
|
2019
Q4 | $1.3M | Buy |
23,724
+304
| +1% | +$14.4K | ﹤0.01% | 1269 |
|
|
2019
Q3 | $873K | Buy |
23,420
+856
| +4% | +$33.3K | ﹤0.01% | 1444 |
|
|
2019
Q2 | $845K | Buy |
22,564
+6,752
| +43% | +$212K | ﹤0.01% | 1450 |
|
|
2019
Q1 | $470K | Buy |
15,812
+2,028
| +15% | +$71.3K | ﹤0.01% | 1791 |
|
|
2018
Q4 | $412K | Sell |
13,784
-4,572
| -25% | -$145K | ﹤0.01% | 1779 |
|
|
2018
Q3 | $656K | Buy |
18,356
+8,584
| +88% | +$266K | ﹤0.01% | 1604 |
|
|
2018
Q2 | $232K | Buy |
+9,772
| New | +$207K | ﹤0.01% | 2338 |
|
|
2017
Q4 | – | Sell |
-16,328
| Closed | -$200K | – | 2690 |
|
|
2017
Q3 | $200K | Sell |
16,328
-5,088
| -24% | -$89.9K | ﹤0.01% | 2288 |
|
|
2017
Q2 | $392K | Buy |
21,416
+7,532
| +54% | +$139K | ﹤0.01% | 1731 |
|
|
2017
Q1 | $294K | Buy |
13,884
+268
| +2% | +$5.23K | ﹤0.01% | 1868 |
|
|
2016
Q4 | $203K | Buy |
13,616
+3,232
| +31% | +$57.3K | ﹤0.01% | 2043 |
|
|
2016
Q3 | $228K | Buy |
+10,384
| New | +$231K | ﹤0.01% | 1912 |
|
|
2016
Q1 | – | Sell |
-10,332
| Closed | -$212K | – | 2224 |
|
|
2015
Q4 | $212K | Buy |
+10,332
| New | +$215K | ﹤0.01% | 1835 |
|
Other funds holding DXCM
SIMG
CC
FFM
PCM
FMI
Commonwealth Equity Services's DXCM Position: Q2 2026 in Review
Commonwealth Equity Services increased its DexCom (DXCM) stake by 21% in Q2 2026, buying an estimated $692K and bringing the position to 59,503 shares worth $4.01M. The position accounts for 0.01% of the portfolio, ranked #1582.
Commonwealth Equity Services first reported a position in DXCM in Q4 2015 and has held it in 39 quarters since. The position peaked at $7.23M in Q1 2024. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Commonwealth Equity Services held 59,503 shares of DexCom worth $4.01M as of Q2 2026.
- Commonwealth Equity Services bought 10,393 DexCom shares in Q2 2026, an estimated $692K.
- DexCom made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1582 holding.
- Commonwealth Equity Services first reported a position in DexCom in Q4 2015 and has held it in 39 quarters since.
- Commonwealth Equity Services's DexCom position peaked at $7.23M in Q1 2024.
- 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.